It was reported that a (b)(6) male patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered a transient ischemic attack.During the procedure, the patient complained of narrowed vision.It occurred about two hours since the procedure was started.Considering the possibility of thromboembolism, the procedure was discontinued when symptoms were confirmed.After consultation with a neurosurgeon, mri was performed.Catheter tip was checked after catheter removal, but no thrombus was found.In the medical examination by a neurosurgeon, there was no evidence of thromboembolism the result of mri showed no abnormality.The physician commented that catheters are unlikely to be the cause.The symptoms improved the next day.There were no abnormal findings in the mri of the brain.The physician suggested possible tension.The physician¿s opinion on the cause of this adverse event is that this is patient condition related.This adverse event was discovered during use of biosense webster products.Patient outcome of the adverse event was reported as improved.There is no further information about the hospitalization.
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4) during an internal review on 09-nov-2021, the patient code of blurred vision (e083901) was removed since transient ischemic attack was already assigned and was reported on the 3500a initial medwatch report # mwr-26102021-0001067305.Please consider this code, blurred vision (e083901), as removed from field h6.Health effect - clinical code.
|
The biosense webster inc.(bwi) product analysis lab received the device for evaluation on (b)(6)2021.The device evaluation was completed on 22-nov-2021.It was reported that a 16-year-old male patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and suffered a transient ischemic attack.During the procedure, the patient complained of narrowed vision.It occurred about two hours since the procedure was started.Considering the possibility of thromboembolism, the procedure was discontinued when symptoms were confirmed.After consultation with a neurosurgeon, mri was performed.Catheter tip was checked after catheter removal, but no thrombus was found.In the medical examination by a neurosurgeon, there was no evidence of thromboembolism the result of mri showed no abnormality.The physician commented that catheters are unlikely to be the cause.The symptoms improved the next day.There were no abnormal findings in the mri of the brain.The physician suggested possible tension.The physician¿s opinion on the cause of this adverse event is that this is patient condition related.This adverse event was discovered during use of biosense webster products.Patient outcome of the adverse event was reported as improved.There is no further information about the hospitalization.Device evaluation details: the device was returned to biosense webster inc.(bwi) for evaluation.Bwi conducted a visual inspection and an evaluation of all features of the catheter.Visual analysis of the returned device revealed that no damage or anomalies were observed on the thermocool® smart touch® sf bi-directional navigation catheter.Per the event, several tests were performed.The magnetic, temperature, and force features were tested, and no issues were observed.In addition, the product was deflecting and irrigating correctly.No malfunctions were observed during the product analysis.A manufacturing record evaluation was performed for the finished device 30482462m number, and no internal actions related to the reported complaint condition were identified.All devices are manufactured, inspected, and released to approved specifications as part of bwi's quality process.No malfunction was observed during the product analysis.The instruction for use states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|